This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299)

Sponsored by Organon and Co

About this trial

Last updated 3 years ago

Study ID

P04299

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
2 to 11 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 18 years ago

What is this trial about?

Evaluate the safety and general clinical response of desloratadine syrup in the relief of symptoms associated with perennial allergic rhinitis in Indonesian pediatric patients.

What are the participation requirements?

Yes

Inclusion Criteria

- Children patients of both sexes aged between 2-11 years, of either gender and any race

- Unequivocal history of perennial allergic rhinitis, including nasal congestion, sneezing, rhinorrhea, pruritus, and lacrimation

- Minimum score for inclusion: 10

- Capable of complying with the dosing regimen

- Free of any clinically significant disease (other than allergic rhinitis)

- Antihistamine must be justified by investigating doctor

No

Exclusion Criteria

- Patients with asthma who require chronic use of inhaled or systemic corticosteroids

- History of frequent, clinically significant sinusitis or chronic purulent postnasal drip

- Patients with rhinitis medicamentosa

- History of hypersensitivity to desloratadine or any of its excipients

- Doctor deems unsuitable